SHANGHAI, March 19 (Reuters) - AstraZeneca said on Thursday it will build a cell therapy manufacturing and supply base and an ...

CEO Bob Valamehr outlined the company’s clinical and manufacturing strategy for FT819, an off-the-shelf allogeneic CAR T-cell ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Dr. John Mellors, who heads the cell therapy discovery team for biotechnology company Galapagos, talks about the innovations the organization is making to improve delivery speed and access to CAR ...

HCW Biologics Inc. (NASDAQ:HCWB) announced new research published in Science Advances indicating that its compound HCW9206 may improve the production of CAR-T cell therapies. The study was carried out ...

Avantor Inc. (NYSE:AVTR) is one of the best large cap stocks to buy under $20. On October 15, Avantor announced a partnership with BlueWhale Bio, which is a commercial-stage company that transforms ...

Under the agreement, Hemogenyx will leverage Made Scientific's specialized expertise in CAR-T cell therapy technology transfer, and manufacturing at its GMP facilities in Newark and Princeton, NJ, ...

Glioblastoma multiforme cells, illustration. Glioblastoma multiforme is a malignant tumor that arises from astrocytes, one of the support cells of the brain. It is an aggressive cancer with a poor ...

Saudi Arabia's cell and gene therapy market is driven by rising demand for innovative treatments targeting chronic and ...

Researchers at UC San Francisco have now developed a way to reprogram these cancer-fighting cells directly inside the body. This new method could remove the need for external manufacturing, ...

Issued on behalf of Avaí Bio, Inc.Companies mentioned in this article: Avaí Bio (OTCQB: AVAI), FibroBiologics (NASDAQ: FBLG), Fate Therapeutics ...

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.